Month: July 2024

FDA Grants Breakthrough Medical Devices Different Treatment Compared to Drugs

FDA Grants Breakthrough Medical Devices Different Treatment Compared to Drugs

The Food and Drug Administration (FDA) uses the “breakthrough” designation to fast-track the development and review of drugs and devices aimed at treating severe conditions, with potential improvements over existing therapies. Despite similar development processes involving significant investment and clinical trials, breakthrough devices face a notably less predictable and longer path to reimbursement compared to […]

Continue Reading

Sun Life Teams Up with Hinge Health for Employee Benefits Collaboration

Sun Life Teams Up with Hinge Health for Employee Benefits Collaboration

Sun Life, an organization focused on employee and government benefits, has recently partnered with Hinge Health to enhance its musculoskeletal (MSK) care offerings through digital solutions. This collaboration will give Sun Life members specialized access to a range of Hinge Health’s services, including health coaching, orthopedic surgery consultations, physical therapy, and technology like surgery decision […]

Continue Reading

The Essential Trio for Modern Clinical Trial Teams: Inclusivity, Innovation, and Scalability

The Essential Trio for Modern Clinical Trial Teams: Inclusivity, Innovation, and Scalability

In the evolving landscape of clinical research, the prioritization of inclusion, innovation, and scalability has become essential for developing treatments that are not only safe and effective but also cater to diverse populations globally. Through leveraging advancements in data and technology, the industry is forging pathways toward more accessible, transformative, and efficient clinical trials. Inclusion […]

Continue Reading

Artiva’s IPO Secures $167M for Advancing NK Cell Therapy in Autoimmune Disease Treatment

Artiva’s IPO Secures $167M for Advancing NK Cell Therapy in Autoimmune Disease Treatment

Artiva Biotherapeutics, a biotech company specializing in innovative cell therapy, has successfully raised $167 million through its initial public offering (IPO), aimed at supporting the clinical trials for their novel treatment approaches for autoimmune diseases. Initially pricing the IPO at $12 per share, which fell below the expected price range of $14 to $16 per […]

Continue Reading

Truvian Health Secures $74M in Funding for Automated Blood Testing Platform

Truvian Health Secures $74M in Funding for Automated Blood Testing Platform

Truvian Health, a company specializing in blood-testing technology, recently announced that it has raised $74 million in funding, securing partnerships with notable entities such as Shoppers Drug Mart, Canada’s largest pharmacy chain. The funding round was co-led by Great Point Ventures and Wittington Ventures, with additional contributions from existing investors like Medical Excellence Capital, Tao […]

Continue Reading

Startup GRObio Secures $60M to Challenge Amgen in Gout Treatment, Enters Clinical Stage

Startup GRObio Secures $60M to Challenge Amgen in Gout Treatment, Enters Clinical Stage

For patients suffering from gout, a painful form of arthritis caused by excess uric acid in the blood, conventional treatments may not always provide relief. In such cases, Amgen’s biologic drug has been a potential alternative, yet its effectiveness is often limited by the immune system which might recognize the therapeutic protein as foreign, initiating […]

Continue Reading

How Four Pre-Market MedTech Firms Utilize Greenlight Guru Quality to Their Advantage

How Four Pre-Market MedTech Firms Utilize Greenlight Guru Quality to Their Advantage

Getting a medical device to market is a complex journey involving design, development, and meticulous adherence to regulatory requirements. A top-tier quality management system (QMS) like Greenlight Guru Quality is crucial for pre-market MedTech companies, providing essential tools to manage documentation, secure necessary approvals, and maintain a compliant, traceable system. Greenlight Guru has been instrumental […]

Continue Reading

Data Management and Reporting Practices in Clinical Trials Regulated by the FDA

Data Management and Reporting Practices in Clinical Trials Regulated by the FDA

Data management and reporting are pivotal aspects of conducting FDA-regulated clinical trials for medical devices. Ensuring the precision, security of clinical data, and adherence to Good Clinical Practice (GCP) are vital for the success of your study and subsequent regulatory submissions to the FDA. This article offers a detailed guide on the FDA’s guidance and […]

Continue Reading